Previous Article | Next Article 
J Virol, May 1998, p. 4015-4021, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Epstein-Barr Virus BARF1 Gene Encodes a Novel,
Soluble Colony-Stimulating Factor-1 Receptor
Laura D.
Strockbine,1
Jeffrey I.
Cohen,2
Terry
Farrah,1,
Stewart D.
Lyman,1
Felecia
Wagener,1
Robert F.
DuBose,1
Richard J.
Armitage,1 and
Melanie
K.
Spriggs1,*
Immunex Corporation, Seattle, Washington
98101,1 and
Laboratory of Clinical
Investigation, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland
208922
Received 29 October 1997/Accepted 29 January 1998
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus associated
with infectious mononucleosis and several tumors. The BARF1 gene is
transcribed early after EBV infection from the BamHI A fragment of the EBV genome. Evidence shown here indicates that the
BARF1 protein is secreted into the medium of transfected cells and from
EBV-carrying B cells induced to allow lytic replication of the virus.
Expression cloning identified colony-stimulating factor-1 (CSF-1) as a
ligand for BARF1. Computer-assisted analyses indicated that subtle
amino acid sequence homology exists between BARF1 and
c-fms, the cellular proto-oncogene that is the receptor for
CSF-1. Recombinant BARF1 protein was found to be biologically active,
and it neutralized the proliferative effects of human CSF-1 in a
dose-dependent fashion when assayed in vitro. Since CSF-1 is a
pleiotropic cytokine best known for its differentiating effects on
macrophages, these data suggest that BARF1 may function to modulate the
host immune response to EBV infection.
*
Corresponding author. Mailing address: Molecular
Biology, Immunex Corporation, 51 University St., Seattle, WA 98101. Phone: (206) 587-0430. Fax: (206) 624-7496. E-mail:
spriggs{at}immunex.com.

Present address: ZymoGenetics, Seattle, WA 98105.
J Virol, May 1998, p. 4015-4021, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Seto, E., Ooka, T., Middeldorp, J., Takada, K.
(2008). Reconstitution of Nasopharyngeal Carcinoma-Type EBV Infection Induces Tumorigenicity. Cancer Res.
68: 1030-1036
[Abstract]
[Full Text]
-
de Turenne-Tessier, M., Ooka, T.
(2007). Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide. J. Gen. Virol.
88: 2656-2661
[Abstract]
[Full Text]
-
Houali, K., Wang, X., Shimizu, Y., Djennaoui, D., Nicholls, J., Fiorini, S., Bouguermouh, A., Ooka, T.
(2007). A New Diagnostic Marker for Secreted Epstein-Barr Virus Encoded LMP1 and BARF1 Oncoproteins in the Serum and Saliva of Patients with Nasopharyngeal Carcinoma. Clin. Cancer Res.
13: 4993-5000
[Abstract]
[Full Text]
-
Ressing, M. E., Keating, S. E., van Leeuwen, D., Koppers-Lalic, D., Pappworth, I. Y., Wiertz, E. J. H. J., Rowe, M.
(2005). Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection. J. Immunol.
174: 6829-6838
[Abstract]
[Full Text]
-
Thompson, M. P., Kurzrock, R.
(2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res.
10: 803-821
[Abstract]
[Full Text]
-
Sheng, W., Decaussin, G., Ligout, A., Takada, K., Ooka, T.
(2003). Malignant Transformation of Epstein-Barr Virus-Negative Akata Cells by Introduction of the BARF1 Gene Carried by Epstein-Barr Virus. J. Virol.
77: 3859-3865
[Abstract]
[Full Text]
-
Vo, Q N, Geradts, J, Gulley, M L, Boudreau, D A, Bravo, J C, Schneider, B G
(2002). Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J. Clin. Pathol.
55: 669-675
[Abstract]
[Full Text]
-
Rivailler, P., Jiang, H., Cho, Y.-g., Quink, C., Wang, F.
(2002). Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model. J. Virol.
76: 421-426
[Abstract]
[Full Text]
-
Cho, Y.-G., Ramer, J., Rivailler, P., Quink, C., Garber, R. L., Beier, D. R., Wang, F.
(2001). An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc. Natl. Acad. Sci. USA
98: 1224-1229
[Abstract]
[Full Text]
-
Decaussin, G., Sbih-Lammali, F., Mireille de Turenne-Tessier, , Bouguermouh, A., Ooka, T.
(2000). Expression of BARF1 Gene Encoded by Epstein-Barr Virus in Nasopharyngeal Carcinoma Biopsies. Cancer Res.
60: 5584-5588
[Abstract]
[Full Text]
-
Hausen, A. z., Brink, A. A. T. P., Craanen, M. E., Middeldorp, J. M., Meijer, C. J. L. M., van den Brule, A. J. C.
(2000). Unique Transcription Pattern of Epstein-Barr Virus (EBV) in EBV-carrying Gastric Adenocarcinomas: Expression of the Transforming BARF1 Gene. Cancer Res.
60: 2745-2748
[Abstract]
[Full Text]
-
Savard, M., Bélanger, C., Tardif, M., Gourde, P., Flamand, L., Gosselin, J.
(2000). Infection of Primary Human Monocytes by Epstein-Barr Virus. J. Virol.
74: 2612-2619
[Abstract]
[Full Text]
-
Parry, C. M., Simas, J. P., Smith, V. P., Stewart, C. A., Minson, A. C., Efstathiou, S., Alcami, A.
(2000). A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus. JEM
191: 573-578
[Abstract]
[Full Text]
-
Deane, D., McInnes, C. J., Percival, A., Wood, A., Thomson, J., Lear, A., Gilray, J., Fleming, S., Mercer, A., Haig, D.
(2000). Orf Virus Encodes a Novel Secreted Protein Inhibitor of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2. J. Virol.
74: 1313-1320
[Abstract]
[Full Text]
-
Cohen, J. I., Lekstrom, K.
(1999). Epstein-Barr Virus BARF1 Protein Is Dispensable for B-Cell Transformation and Inhibits Alpha Interferon Secretion from Mononuclear Cells. J. Virol.
73: 7627-7632
[Abstract]
[Full Text]
-
van Berkel, V., Preiter, K., Virgin, H. W. IV, Speck, S. H.
(1999). Identification and Initial Characterization of the Murine Gammaherpesvirus 68 Gene M3, Encoding an Abundantly Secreted Protein. J. Virol.
73: 4524-4529
[Abstract]
[Full Text]